MentionFox
Home › Executive changes › Usana Health Sciences Inc
Leadership changes · USNA · SEC Form 8-K, Item 5.02

Leadership changes at Usana Health Sciences Inc (2026)

Before you join, sell to or invest in Usana Health Sciences Inc

MentionFox check on Usana Health Sciences Inc: only 2 sources on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/usana-health-sciences

Check Usana Health Sciences Inc before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Usana Health Sciences Inc?

Who joined and who left Usana Health Sciences Inc (USNA)? 1 appointment reported from 2026-01-08 to 2026-02-11, each cited to the company's own filing.

Kevin Guest was named Chief Executive Officer of Usana Health Sciences Inc. As of November 14, 2026, Usana Health Sciences Inc has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from January 8, 2026 to February 11, 2026, naming 1 appointment (Form 8-K, January 8, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

PZENA INVESTMENT MANAGEMENT LLC also filed stake reports on 37 other companies ↓

Sell to companies like Usana Health Sciences Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes2
In (appointed)1
Latest filing2026-02-11

Usana Health Sciences Inc reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-01-08 to 2026-02-11. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Usana Health Sciences Inc files it.

Also on the record for Usana Health Sciences Inc

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G, by Nantahala Capital Management, LLC5.35% of the class5%+ stakesSource
August 13, 2026Stake report, Schedule 13G/A, by Renaissance Technologies LLC5.19% of the class5%+ stakesSource
March 30, 2026Stake report, Schedule 13D/A, by Myron W. Wentz40.1% of the class5%+ stakesSource
March 27, 2026Stake report, Schedule 13G/A, by The Vanguard Group—5%+ stakesSource
January 21, 2026Stake report, Schedule 13G/A, by BlackRock, Inc.4.4% of the class5%+ stakesSource
January 21, 2026Stake report, Schedule 13G/A, by Dimensional Fund Advisors LP4.6% of the class5%+ stakesSource
October 14, 2025Stake report, Schedule 13G/A, by PZENA INVESTMENT MANAGEMENT LLC6.6% of the class5%+ stakesSource
October 9, 2025Stake report, Schedule 13G, by Dimensional Fund Advisors LP5% of the class5%+ stakesSource
July 29, 2025Stake report, Schedule 13G/A, by The Vanguard Group5.43% of the class5%+ stakesSource

Selling to them or working with them? See who runs Usana Health Sciences Inc now and the warning signs.

Free to see. No signup.

Keep reading

More on Usana Health Sciences Inc and the records around it.

Usana Health Sciences Inc elsewhere on the record

Companies that share a holder

Want the whole picture on Usana Health Sciences Inc?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Usana Health Sciences Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Usana Health Sciences Inc covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    11 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-02-11Reportednot named in the filing8-K/A, 2026-02-11
2026-01-08InChief Executive Officer8-K, 2026-01-08

Who leads Usana Health Sciences Inc, as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Usana Health Sciences Inc?

New leaders reset buying decisions — get the Full Report on Usana Health Sciences Inc: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Usana Health Sciences Inc

Hiring for a seat like this?

Find people with the same kind of experience as the Chief Executive Officer at Usana Health Sciences Inc, with the record behind each one.

Find candidates like Chief Executive Officer at Usana Health Sciences Inc

Every change, in the filing's words

Filed 2026-02-11 · 8-K/A

Reported

that Jim Brown stepped down as the Company's Chief Executive Officer and President, and that Kevin Guest, the Company's Chairman of the Board, reassumed the role of Chief Executive Officer.

Also stated in this filing

  • At the time of the Initial 8-K, the Compensation Committee of the Board (the "Compensation Committee") had not determined the compensation arrangements for Mr. Brown or Mr. Guest.
  • Mr. Brown On February 5, 2026, the Company and Mr. Brown entered into a Transition Agreement (the "Transition Agreement") which documents his transition from the Company's Chief Executive Officer and President to a strategic advisor to Mr. Guest and the Company from January 7, 2026, through December 31, 2026 (the "Transition Period").
  • Mr. Brown's employment as a strategic advisor will end on December 31, 2026 (the "Separation Date").
  • While Mr. Brown serves as a strategic advisor during the Transition Period, he will receive payment of (i) his base salary of $825,000; (ii) his earned, but unpaid, executive bonus for the 2025 fiscal year, payable in accordance with the Company's standard practices; and (iii) medical and other benefits, similar to those available to eligible employees of the Company.
  • Mr. Brown will remain eligible to exercise all equity awards issued to him, which vest prior to the Separation Date.
  • All equity awards issued to Mr. Brown, which have not vested as of the Separation Date will be cancelled.
Filed 2026-01-08 · 8-K

Appointed: Kevin Guest, Chief Executive Officer

In August 2014, Mr. Guest was appointed President of USANA and in August 2015, he was appointed Co-Chief Executive Officer.

Also stated in this filing

  • On January 8, 2026, USANA Health Sciences, Inc. (the "Company" or "USANA") announced a leadership transition pursuant to which Jim Brown stepped down as Chief Executive Officer and President of the Company.
  • Mr. Brown will remain with the Company in an advisory role for a period at the discretion of the Board of Directors.
  • As part of this transition, Kevin Guest, 63, who currently serves as Executive Chairman of the Board and previously served as Chief Executive Officer, will reassume the role of Chief Executive Officer.
  • Mr. Guest will also continue to serve as Chairman of the Board.
  • The Compensation Committee of the Board of Directors has not yet determined the material terms of Mr. Brown's compensation arrangements in connection with his separation from the Company.
  • The Compensation Committee expects to make such determinations shortly.
  • The Compensation Committee expects to make such determinations shortly.
  • In the interim, Mr. Guest will continue to receive his previously approved compensation as Executive Chairman of the Board.
  • Following the Company's acquisition of the media, video, and event-productions company FMG Productions founded by Mr. Guest, he became a full-time employee of the Company and was promoted to Vice President of Media and Events in February 2004.

Tools for this story

Each opens in a new tab, filled in for Usana Health Sciences Inc. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/usana-health-sciences
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Who joined Usana Health Sciences Inc? (2026). MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/usana-health-sciences